Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sung-bae Kim, M.D., Ph.D
Asan Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Oncology Complex Center - Burgas'' Ltd., Medical Oncology Department
Burgas, Bulgaria
- Multi-Profile Hospital for Active Treatment Uni Hospital Ltd. Medical Oncology Department
Panagyurishte, Bulgaria
- Medical Center Nadezhda Clinical" Ltd.,
Sofia, Bulgaria
- Anhui Cancer Hospital
Hefei, Anhui, China
- Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Hainan Medical College
Haikou, Hainan, China
- Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
- Tianjin Cancer Hospital
Zhengzhou, Henan, China
- Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
- Jiangsu Province Hospital
Nanjing, Jiangsu, China
- First Affiliated Hospital of Jilin University
Changchun, Jilin, China
- Liaoning Cancer Hospital
Shenyang, Liaoning, China
- Shangdong Cancer Hospital
Jinan, Shandong, China
- Linyi Cancer Hospital
Linyi, Shandong, China
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
- the First Affiliated Hospital of Xi'An Jiaotong University
Xi’an, Shanxi, China
- West China School of Medicine Sichuan University
Chengdu, Sichuan, China
- Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
- Zhejiang University School of Medicine Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
- Henan Cancer Hospital
Zhengzhou, China
- Tolna County Balassa János Hospital
Szekszárd, Hungary
- Szent Borbála Hospital
Tatabánya, Hungary
- Clinical Hospital Center Bežanijska Kosa, Department of Oncology
Belgrade, Serbia
- Institute for Oncology and Radiology of Serbia
Belgrade, Serbia
- Oncology Institute of Vojvodina
Kamenitz, Serbia
- Health Center Kladovo, Oncology Department
Kladovo, Serbia
- Clinical Center Kragujevac Center of Oncology and Radiotherapy
Kragujevac, Serbia
- General Hospital Krusevac, Outpatient Clinic for Chemotherapy
Kruševac, Serbia
- Clinical Center Niš, Clinic for Oncology
Niš, Serbia
- Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, South Korea
- National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
- Cha University Cha Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea
- Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
- Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea
- Inje University Haeundae Paik Hospital
Busan, South Korea
- Kosin University Gospel Hospital
Busan, South Korea
- Pusan National University Yangsan Hospital
Busan, South Korea
- Keimyung University Dongsan Medical Center
Daegu, South Korea
- Konyang University Hospital
Daejeon, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2017
- Primary completion
- 19 Feb 2024
- Completion
- 30 Nov 2028
- Last update posted
- 1 Apr 2026
- Registered enrollment
- 549
- Registry id
- NCT03315364
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.